169 related articles for article (PubMed ID: 3495637)
21. The prevalence of multiple sclerosis in the Outer Hebrides compared with north-east Scotland and the Orkney and Shetland Islands.
Dean G; Goodall J; Downie A
J Epidemiol Community Health; 1981 Jun; 35(2):110-3. PubMed ID: 7299334
[TBL] [Abstract][Full Text] [Related]
22. Prognostic indicators in multiple sclerosis.
Poser S; Poser W; Schlaf G; Firnhaber W; Lauer K; Wolter M; Evers P
Acta Neurol Scand; 1986 Nov; 74(5):387-92. PubMed ID: 3825497
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of multiple sclerosis in the north-west Italian province of Genoa.
Solaro C; Allemani C; Messmer Uccelli M; Canevari E; Dagnino N; Pizio R; Regesta G; Tanganelli P; Battaglia MA; Mancardi GL
J Neurol; 2005 Apr; 252(4):436-40. PubMed ID: 15726261
[TBL] [Abstract][Full Text] [Related]
24. The natural history of multiple sclerosis: a regional study with some longitudinal data.
Miller DH; Hornabrook RW; Purdie G
J Neurol Neurosurg Psychiatry; 1992 May; 55(5):341-6. PubMed ID: 1602305
[TBL] [Abstract][Full Text] [Related]
25. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
26. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.
Confavreux C; Aimard G; Devic M
Brain; 1980 Jun; 103(2):281-300. PubMed ID: 7397479
[TBL] [Abstract][Full Text] [Related]
27. A further prevalence study of multiple sclerosis in north-east Scotland.
Shepherd DI; Downie AW
J Neurol Neurosurg Psychiatry; 1980 Apr; 43(4):310-5. PubMed ID: 6966323
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models.
Riise T; Grønning M; Aarli JA; Nyland H; Larsen JP; Edland A
J Clin Epidemiol; 1988; 41(10):1031-6. PubMed ID: 3193137
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of multiple sclerosis in a south London borough.
Williams ES; McKeran RO
Br Med J (Clin Res Ed); 1986 Jul; 293(6541):237-9. PubMed ID: 3089468
[TBL] [Abstract][Full Text] [Related]
30. Long-term survival experience of patients with multiple sclerosis.
Pokorski RJ
J Insur Med; 1997; 29(2):101-6. PubMed ID: 10169627
[TBL] [Abstract][Full Text] [Related]
31. Trends in survival and cause of death in Danish patients with multiple sclerosis.
Brønnum-Hansen H; Koch-Henriksen N; Stenager E
Brain; 2004 Apr; 127(Pt 4):844-50. PubMed ID: 14960501
[TBL] [Abstract][Full Text] [Related]
32. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension.
Myhr KM; Riise T; Vedeler C; Nortvedt MW; Grønning R; Midgard R; Nyland HI
Mult Scler; 2001 Feb; 7(1):59-65. PubMed ID: 11321195
[TBL] [Abstract][Full Text] [Related]
33. Survival and cause of death in multiple sclerosis: a prospective population-based study.
Hirst C; Swingler R; Compston DA; Ben-Shlomo Y; Robertson NP
J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1016-21. PubMed ID: 18303108
[TBL] [Abstract][Full Text] [Related]
34. Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland.
Gudi VS; White MI; Cruickshank N; Herriot R; Edwards SL; Nimmo F; Ormerod AD
Br J Dermatol; 2005 Aug; 153(2):424-7. PubMed ID: 16086760
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics and long term prognosis in early onset multiple sclerosis.
Deryck O; Ketelaer P; Dubois B
J Neurol; 2006 Jun; 253(6):720-3. PubMed ID: 16502213
[TBL] [Abstract][Full Text] [Related]
36. Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry.
Koch-Henriksen N; Brønnum-Hansen H; Stenager E
J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):56-9. PubMed ID: 9667561
[TBL] [Abstract][Full Text] [Related]
37. Long-term survival of patients with multiple sclerosis in West France.
Leray E; Morrissey S; Yaouanq J; Coustans M; Le Page E; Chaperon J; Edan G
Mult Scler; 2007 Aug; 13(7):865-74. PubMed ID: 17881399
[TBL] [Abstract][Full Text] [Related]
38. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
39. [Survival in amyotrophic lateral sclerosis].
Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
[TBL] [Abstract][Full Text] [Related]
40. Mortality rates from multiple sclerosis: geographical and temporal variations revisited.
Williams ES; Jones DR; McKeran RO
J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):104-9. PubMed ID: 2019834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
